Monday, January 24, 2022

Omicron May Not Evade All Monoclonal Antibodies, Study Suggests

The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.

from NDTV News - World-news https://ift.tt/33LnQKT
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Indian-American Executive Ajay Anand Named To Leadership Role At Wharton

An Indian-American executive has been named to a leadership role at an inaugural programme at the prestigious Wharton School, bringing his i...